INGN (Inogen, Inc.) Stock Financials & Earnings

INGNInogen, Inc.

Mkt Cap$171M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$349M

Net Income (TTM)-$23M

EPS (TTM)-$0.86

Free Cash Flow (TTM)-$21M

Gross Margin47.6%

Op. Margin-8.7%

Net Margin-6.5%

FCF Margin-6.1%

P/S Ratio (TTM)0.5x

P/E Ratio (TTM)—

YoY Rev Growth+3.9%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$72M	$31M	-$22M
Q2 23	$84M	$34M	-$12M
Q3 23	$84M	$34M	-$47M
Q4 23	$76M	$28M	-$29M
Q1 24	$78M	$34M	-$16M
Q2 24	$89M	$43M	-$7M
Q3 24	$89M	$41M	-$8M
Q4 24	$80M	$36M	-$11M
Q1 25	$82M	$36M	-$8M
Q2 25	$92M	$41M	-$6M
Q3 25	$92M	$47M	-$7M
Q4 25	$82M	$41M	-$9M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$5M	$19M	$28M
Q2 23	$4M	$15M	$27M
Q3 23	$4M	$17M	$26M
Q4 23	$7M	$25M	$26M
Q1 24	$7M	$17M	$27M
Q2 24	$6M	$19M	$26M
Q3 24	$4M	$19M	$26M
Q4 24	$6M	$18M	$24M
Q1 25	$4M	$16M	$24M
Q2 25	$5M	$17M	$25M
Q3 25	$5M	$18M	$25M
Q4 25	$5M	$16M	$23M

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$164M	$10M	$175M
Q2 23	$168M	$2M	$170M
Q3 23	$125M	$13M	$138M
Q4 23	$125M	$3M	$128M
Q1 24	$107M	$12M	$120M
Q2 24	$98M	$20M	$118M
Q3 24	$106M	$15M	$121M
Q4 24	$114M	$0	$114M
Q1 25	$119M	$0	$119M
Q2 25	$104M	$19M	$122M
Q3 25	$108M	$17M	$125M
Q4 25	$104M	$16M	$120M

Shares Outstanding

Revenue Per Employee

Revenue / Employee